1. Home
  2. TEVA vs FTV Comparison

TEVA vs FTV Comparison

Compare TEVA & FTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • FTV
  • Stock Information
  • Founded
  • TEVA 1901
  • FTV 2015
  • Country
  • TEVA Israel
  • FTV United States
  • Employees
  • TEVA N/A
  • FTV N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • FTV Industrial Machinery/Components
  • Sector
  • TEVA Health Care
  • FTV Industrials
  • Exchange
  • TEVA Nasdaq
  • FTV Nasdaq
  • Market Cap
  • TEVA 20.1B
  • FTV 23.9B
  • IPO Year
  • TEVA N/A
  • FTV N/A
  • Fundamental
  • Price
  • TEVA $17.15
  • FTV $53.00
  • Analyst Decision
  • TEVA Strong Buy
  • FTV Buy
  • Analyst Count
  • TEVA 8
  • FTV 14
  • Target Price
  • TEVA $24.50
  • FTV $77.58
  • AVG Volume (30 Days)
  • TEVA 10.5M
  • FTV 4.1M
  • Earning Date
  • TEVA 07-30-2025
  • FTV 07-30-2025
  • Dividend Yield
  • TEVA N/A
  • FTV 0.60%
  • EPS Growth
  • TEVA N/A
  • FTV N/A
  • EPS
  • TEVA N/A
  • FTV 2.28
  • Revenue
  • TEVA $16,616,000,000.00
  • FTV $6,181,500,000.00
  • Revenue This Year
  • TEVA $5.69
  • FTV N/A
  • Revenue Next Year
  • TEVA N/A
  • FTV $2.77
  • P/E Ratio
  • TEVA N/A
  • FTV $23.25
  • Revenue Growth
  • TEVA 3.82
  • FTV 0.85
  • 52 Week Low
  • TEVA $12.47
  • FTV $45.51
  • 52 Week High
  • TEVA $22.80
  • FTV $62.79
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 50.50
  • FTV 48.82
  • Support Level
  • TEVA $16.55
  • FTV $50.00
  • Resistance Level
  • TEVA $16.95
  • FTV $54.24
  • Average True Range (ATR)
  • TEVA 0.43
  • FTV 1.09
  • MACD
  • TEVA -0.06
  • FTV -0.03
  • Stochastic Oscillator
  • TEVA 45.04
  • FTV 71.93

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About FTV Fortive Corporation

Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.

Share on Social Networks: